Welcome to the new Regeneron Newsroom. This newsroom is designed to provide members of the media with easy access to up-to-date information about the Company. If you are a reporter with a question about Regeneron, please call our Media Line at (914) 847-7800.
For an e-mail response to questions about Regeneron, please contact us at media@regeneron.com .
Feb 21, 2012
Regeneron Announces February 2012 Investor Conference Presentations
Feb 13, 2012
Regeneron Announces Presentation at the Leerink Swann 2012 Global Healthcare Conference
Feb 13, 2012
Regeneron Reports Fourth Quarter and Full Year 2011 Financial and Operating Results
Feb 10, 2012
Regeneron Announces February 13, 2012 as Date of Full Year 2011 Financial and Operating Results Conference Call and Webcast
Jan 26, 2012
Regeneron to Report Full Year 2011 Financial and Operating Results and Host Conference Call and Webcast on February 16, 2012
Jan 3, 2012
Regeneron Announces Presentation at the 30th Annual J. P. Morgan Healthcare Conference
Jan 3, 2012
Regeneron Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA™ (aflibercept) Injection
Jan 2, 2012
Regeneron to Host Conference Call on January 3 at 8:30 a.m. Eastern Time to Discuss Ongoing Patent Litigation
Dec 5, 2011
Two Year Results of Phase 3 Studies with EYLEA™ (aflibercept) Injection in wet AMD Show Sustained Improvement in Visual Acuity
Dec 1, 2011
Regeneron Announces Presentation Time Change at the 2011 Deutsche Bank BioFEST
Shareholder Briefcase
E-mail Alerts
Download Library
REGN Snapshot
RSS News Feeds
Citi 2012 Global Healthcare Conference
